The policy committee decided to approve all six directors recommended by Song Young-sook and Lim Ju-hyeon… “Consistent with enhancing shareholder value”
LS Koo Ja-eun and Samyang Foods vote against the appointment of executive director Kim Jeong-su… “History of damaging corporate value”
DB HiTek is ‘against’ changing the Articles of Incorporation and ‘is in favor’ of appointing a director.
President Joohyun Lim answers questions
(Seoul = Larose.VIP) Reporter Kim Byeong-gyu = The National Pension Service sided with the mother and daughter in the management rights dispute between them over Hanmi Pharmaceutical Group.
The National Pension Fund Trustee Responsibility Expert Committee (Fiduciary Committee, Chairman Han Seok-hoon) held a meeting on the 26th to deliberate on the agenda for the regular general shareholders’ meeting of Hanmi Science to be held on the 28th and to appoint directors and auditors recommended by Hanmi Science’s current management led by Hanmi Group Chairman Song Young-sook. Everyone decided to agree with the agenda.
Directors and auditors recommended by the current management include executive directors Lim Joo-hyun and Lee Woo-hyun, non-executive directors Choi In-young, outside directors Kim Ha-il, Seo Jeong-mo, and Park Gyeong-jin, and audit committee members Seo Jeong-mo and Park Gyeong-jin.
Meanwhile, the committee decided to oppose all proposals for the appointment of executive directors Lim Jong-yoon and Lim Jong-hoon, other non-executive directors Kwon Gyu-chan and Bae Bo-kyung, and outside directors Sabong-gwan proposed by the eldest and second sons of the same family, Lim Jong-yoon, president of Hanmi Pharmaceutical, and Lim Jong-hoon, CEO of Hanmi Fine Chemical. decided.
The Accountability Committee explained, “With regard to the agenda for the appointment of directors and audit committee members, where the board of directors’ plan and shareholder proposals were competing, we judged that the board’s plan was more suitable for enhancing long-term shareholder value.”
As a result, Chairman Song Young-sook and Hanmi Science President Lim Joo-hyeon are in an advantageous position in the dispute over Hanmi Science’s management rights. Additionally, the integration of Hanmi Pharmaceutical Group and OCI Group, promoted by her mother and daughter, has also gained momentum.
Hanmi Science is the holding company of Hanmi Pharmaceutical. The National Pension Service owns a 7.66% stake in Hanmi Science, so it is evaluated as having a casting vote in this management dispute.
Meanwhile, the management committee decided to vote against the appointment of executive director Koo Ja-eun, which was on the agenda of the LS regular general shareholders’ meeting, and the appointment of executive director Kim Jeong-su, which was on the agenda of the Samyang Food shareholders’ meeting, citing “history of damaging corporate value.”
In relation to DB HiTek’s shareholders’ meeting agenda, it was decided to change the number of directors from ‘4 or more’ to ‘4 to 8 or less’ and to oppose the change in the articles of incorporation that makes the cancellation of treasury stock the right of the shareholders’ meeting.
In addition, it was decided against the cancellation of treasury stock that presupposes a change in the articles of incorporation, and it was decided in favor of the appointment of executive director Lee Sang-gi, outside director and audit committee member Hwang Cheol-seong, and audit committee members Yoon Young-mok and Han Seung-yeop.
bkkim@yna.co.kr
Report to KakaoTalk okjebo
